According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

Company Pfizer
2019 Racionalʹnaâ Farmakoterapiâ v Kardiologii  
Pfizer Company Press Release.
doaj:3fa4a496beba463890aa6809bd4e853c fatcat:b4mzp336yfehjpm2zacmxoxkj4